NO992665L - Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA - Google Patents
Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNAInfo
- Publication number
- NO992665L NO992665L NO992665A NO992665A NO992665L NO 992665 L NO992665 L NO 992665L NO 992665 A NO992665 A NO 992665A NO 992665 A NO992665 A NO 992665A NO 992665 L NO992665 L NO 992665L
- Authority
- NO
- Norway
- Prior art keywords
- administering
- compositions
- methods
- pneumococcal dna
- pneumococcal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75950596A | 1996-12-04 | 1996-12-04 | |
| PCT/US1997/022847 WO1998024927A1 (en) | 1996-12-04 | 1997-12-04 | Compositions and methods for administering pneumococcal dna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO992665D0 NO992665D0 (no) | 1999-06-02 |
| NO992665L true NO992665L (no) | 1999-08-04 |
Family
ID=25055905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO992665A NO992665L (no) | 1996-12-04 | 1999-06-02 | Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20020102242A1 (de) |
| EP (1) | EP1019522A4 (de) |
| JP (1) | JP2002514061A (de) |
| AU (1) | AU5523798A (de) |
| CA (1) | CA2274095A1 (de) |
| IL (1) | IL130291A0 (de) |
| NO (1) | NO992665L (de) |
| WO (1) | WO1998024927A1 (de) |
| ZA (1) | ZA9710934B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002362447A1 (en) * | 2001-10-03 | 2003-04-14 | University Of Rochester | Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2 |
| WO2010141312A2 (en) | 2009-06-01 | 2010-12-09 | Wake Forest University Health Sciences | Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
| US9175119B2 (en) | 2011-12-14 | 2015-11-03 | Ineos Europe Ag | Polymers |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA921025B (en) * | 1991-02-15 | 1992-11-25 | Uab Research Foundation | Structural gene of pneumococcal protein |
| US5476929A (en) * | 1991-02-15 | 1995-12-19 | Uab Research Foundation | Structural gene of pneumococcal protein |
-
1997
- 1997-12-04 AU AU55237/98A patent/AU5523798A/en not_active Abandoned
- 1997-12-04 ZA ZA9710934A patent/ZA9710934B/xx unknown
- 1997-12-04 JP JP52589598A patent/JP2002514061A/ja active Pending
- 1997-12-04 EP EP97951660A patent/EP1019522A4/de not_active Withdrawn
- 1997-12-04 CA CA002274095A patent/CA2274095A1/en not_active Abandoned
- 1997-12-04 IL IL13029197A patent/IL130291A0/xx unknown
- 1997-12-04 WO PCT/US1997/022847 patent/WO1998024927A1/en not_active Application Discontinuation
-
1999
- 1999-06-02 NO NO992665A patent/NO992665L/no not_active Application Discontinuation
-
2001
- 2001-04-27 US US09/844,645 patent/US20020102242A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1019522A4 (de) | 2002-06-19 |
| JP2002514061A (ja) | 2002-05-14 |
| ZA9710934B (en) | 1998-09-10 |
| IL130291A0 (en) | 2000-06-01 |
| AU5523798A (en) | 1998-06-29 |
| WO1998024927A1 (en) | 1998-06-11 |
| EP1019522A1 (de) | 2000-07-19 |
| NO992665D0 (no) | 1999-06-02 |
| US20020102242A1 (en) | 2002-08-01 |
| CA2274095A1 (en) | 1998-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL127545A0 (en) | Compositions and methods for administering borrelia DNA | |
| NO973046D0 (no) | Elastiske sementsammensetninger og fremgangsmåte | |
| NO973048L (no) | Elastiske brönnsementsammensetninger og fremgangsmåter | |
| NO985196D0 (no) | Dispergerbare makromolekylblandinger og fremgangsmÕter for deres fremstilling og anvendelse | |
| ATE351910T1 (de) | Ob-fusionsprotein enthaltende zusammensetzungen und verfahren | |
| GB2331015B (en) | Therapeutic methods and compositions involving isoflavones | |
| CY2013008I1 (el) | Πεπτιδιο κατασταλτικο της ορεξης, συνθεσεις και χρηση αυτου | |
| NO991676L (no) | FremgangsmÕter og sammensetninger for immunmodulering | |
| ATE236898T1 (de) | S-omeprazol in festform | |
| DE69717853D1 (de) | Verpacktes lichthärtbares gemisch | |
| ID17860A (id) | Komposisi vaksin | |
| NO985385L (no) | Bitumensammensetninger og fremgangsmÕte for fremstilling derav | |
| BR9709701A (pt) | Composição em barra | |
| NO992665L (no) | Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA | |
| DE69714504D1 (de) | Benzothiopene, diese enthaltende Zubereitungen und Verfahren | |
| DK0910369T3 (da) | Benzothiophener, formuleringer indeholdende samme og fremgangsmåder | |
| NO983802D0 (no) | Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter | |
| NO991749D0 (no) | Sammensetninger til bruk i betong og betongprodukter fremstilt derav | |
| ID19246A (id) | Komposisi oral antikalkulus | |
| NO973047D0 (no) | Elastiske sementsammensetninger og fremgangsmåter | |
| ID19099A (id) | Komposisi oral | |
| NO952766D0 (no) | Opplösningsmiddelsammensetninger og metoder | |
| GB9617346D0 (en) | Therapeutic methods and compositions for use therein | |
| GB9603471D0 (en) | Therapeutic methods and compositions for use therein | |
| KR970060794U (ko) | 다용도 팽이 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |